Margit MacDougall

634 total citations
12 papers, 273 citations indexed

About

Margit MacDougall is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Margit MacDougall has authored 12 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Margit MacDougall's work include Diabetes Treatment and Management (7 papers), Pancreatic function and diabetes (5 papers) and Receptor Mechanisms and Signaling (4 papers). Margit MacDougall is often cited by papers focused on Diabetes Treatment and Management (7 papers), Pancreatic function and diabetes (5 papers) and Receptor Mechanisms and Signaling (4 papers). Margit MacDougall collaborates with scholars based in United States, Australia and Germany. Margit MacDougall's co-authors include James N. Livingston, Stephanie Yung, Clark Q. Pan, Jianxin Yang, Irene Tom, William J. Zavadoski, Ru Wei, Over Cabrera, Kevin B. Clairmont and Michael T. McDowell and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Margit MacDougall

12 papers receiving 268 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margit MacDougall United States 9 161 140 111 65 33 12 273
János T. Kodra Denmark 9 178 1.1× 88 0.6× 60 0.5× 52 0.8× 15 0.5× 13 274
Pernille Wismann Denmark 7 245 1.5× 218 1.6× 141 1.3× 109 1.7× 26 0.8× 8 402
Tine Glendorf Denmark 9 143 0.9× 186 1.3× 147 1.3× 26 0.4× 13 0.4× 17 325
Imelda Calderon United States 5 232 1.4× 127 0.9× 73 0.7× 56 0.9× 28 0.8× 5 320
Holly J. Clarke United States 7 266 1.7× 165 1.2× 141 1.3× 66 1.0× 23 0.7× 8 393
Ronald W. Steigerwalt United States 13 260 1.6× 55 0.4× 108 1.0× 178 2.7× 89 2.7× 22 452
Charles Xing United States 8 211 1.3× 185 1.3× 113 1.0× 98 1.5× 88 2.7× 20 424
Guorui Zhang China 10 104 0.6× 47 0.3× 44 0.4× 33 0.5× 16 0.5× 27 281
MH Mooney United Kingdom 11 138 0.9× 323 2.3× 144 1.3× 176 2.7× 124 3.8× 13 412
Ryotaro Kojima Japan 9 261 1.6× 56 0.4× 34 0.3× 30 0.5× 28 0.8× 15 367

Countries citing papers authored by Margit MacDougall

Since Specialization
Citations

This map shows the geographic impact of Margit MacDougall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margit MacDougall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margit MacDougall more than expected).

Fields of papers citing papers by Margit MacDougall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margit MacDougall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margit MacDougall. The network helps show where Margit MacDougall may publish in the future.

Co-authorship network of co-authors of Margit MacDougall

This figure shows the co-authorship network connecting the top 25 collaborators of Margit MacDougall. A scholar is included among the top collaborators of Margit MacDougall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margit MacDougall. Margit MacDougall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
MacDougall, Margit, Steven Kerr, Hu Sheng Qian, et al.. (2022). Effect of Novel Biotherapeutic Elevating Angiopoietin 1 on Progression of Diabetic Nephropathy in Diabetic/Obese Mice. Journal of Pharmacology and Experimental Therapeutics. 382(3). 266–276. 1 indexed citations
2.
MacDougall, Margit, et al.. (2018). Non-neutralizing antibodies increase endogenous circulating Ang1 levels. mAbs. 10(8). 1260–1268. 5 indexed citations
3.
Stevens, Benjamin D., John Litchfield, Jeffrey A. Pfefferkorn, et al.. (2013). Discovery of an intravenous hepatoselective glucokinase activator for the treatment of inpatient hyperglycemia. Bioorganic & Medicinal Chemistry Letters. 23(24). 6588–6592. 10 indexed citations
4.
Yang, Jianxin, Margit MacDougall, Michael T. McDowell, et al.. (2011). Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes. BMC Genomics. 12(1). 281–281. 66 indexed citations
5.
Wunderlich, D., et al.. (2007). Generation and Characterization of a Monoclonal IgG Antibody to Polyethylene Glycol. Hybridoma. 26(3). 168–172. 10 indexed citations
6.
Pan, Clark Q., Joanne Buxton, Stephanie Yung, et al.. (2006). Design of a Long Acting Peptide Functioning as Both a Glucagon-like Peptide-1 Receptor Agonist and a Glucagon Receptor Antagonist. Journal of Biological Chemistry. 281(18). 12506–12515. 64 indexed citations
7.
Yung, Stephanie, Sarah Hamren, Jian Zhu, et al.. (2003). Generation of Highly Selective VPAC2 Receptor Agonists by High Throughput Mutagenesis of Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Peptide. Journal of Biological Chemistry. 278(12). 10273–10281. 37 indexed citations
8.
Ladouceur, Gaétan, James H. Cook, Donald L. Hertzog, et al.. (2002). Integration of optimized substituent patterns to produce highly potent 4-aryl-pyridine glucagon receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 12(23). 3421–3424. 8 indexed citations
9.
Ladouceur, Gaétan, James H. Cook, Elizabeth M. Doherty, et al.. (2002). Discovery of 5-Hydroxyalkyl-4-phenylpyridines as a New Class of Glucagon Receptor Antagonists. Bioorganic & Medicinal Chemistry Letters. 12(3). 461–464. 26 indexed citations
10.
Smith, Roger A., Donald L. Hertzog, Martin H. Osterhout, et al.. (2002). Optimization of the 4-aryl group of 4-aryl-pyridine glucagon antagonists: development of an efficient, alternative synthesis. Bioorganic & Medicinal Chemistry Letters. 12(9). 1303–1306. 13 indexed citations
11.
Buggy, Joseph J., Rainer O. Heurich, Margit MacDougall, et al.. (1997). Role of the Glucagon Receptor COOH-Terminal Domain in Glucagon-Mediated Signaling and Receptor Internalization. Diabetes. 46(9). 1400–1405. 26 indexed citations
12.
Buggy, Joseph J., et al.. (1996). Human Glucagon Receptor Monoclonal Antibodies: Antagonism of Glucagon Action and Use in Receptor Characterization. Hormone and Metabolic Research. 28(5). 215–219. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026